Super Retail Group Limited (ASX:SUL)
Australia · Delayed Price · Currency is AUD 15.86
-0.06 (-0.38%)
Aug 8, 2025, 4:10 PM AEST
Intra-Cellular Therapies Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 28, 2024 | Jun '24 Jun 29, 2024 | Jul '23 Jul 1, 2023 | Jul '22 Jul 2, 2022 | Jun '21 Jun 26, 2021 | Jun '20 Jun 27, 2020 | 2016 - 2020 |
Operating Revenue | 3,963 | 3,883 | 3,803 | 3,551 | 3,453 | 2,825 | Upgrade |
Other Revenue | - | - | - | - | 0.4 | 0.2 | Upgrade |
| 3,963 | 3,883 | 3,803 | 3,551 | 3,454 | 2,825 | Upgrade | |
Revenue Growth (YoY) | 2.40% | 2.10% | 7.09% | 2.82% | 22.23% | 4.20% | Upgrade |
Cost of Revenue | 2,143 | 2,085 | 2,045 | 1,890 | 1,797 | 1,555 | Upgrade |
Gross Profit | 1,820 | 1,798 | 1,758 | 1,661 | 1,656 | 1,270 | Upgrade |
Selling, General & Admin | 1,444 | 1,409 | 1,335 | 1,268 | 1,188 | 1,059 | Upgrade |
Operating Expenses | 1,444 | 1,409 | 1,335 | 1,268 | 1,188 | 1,059 | Upgrade |
Operating Income | 376.4 | 389.2 | 422.4 | 393 | 468.8 | 211.5 | Upgrade |
Interest Expense | -63.1 | -57.8 | -47.4 | -47 | -41 | -55.1 | Upgrade |
Interest & Investment Income | 6.5 | 8.2 | 4.2 | - | - | - | Upgrade |
Earnings From Equity Investments | - | - | - | -0.4 | -0.2 | -0.6 | Upgrade |
Other Non Operating Income (Expenses) | 0.1 | 0.2 | 0.2 | 0.1 | - | - | Upgrade |
EBT Excluding Unusual Items | 319.9 | 339.8 | 379.4 | 345.7 | 427.6 | 155.8 | Upgrade |
Pretax Income | 320.5 | 339.8 | 379.4 | 345.7 | 427.6 | 155.8 | Upgrade |
Income Tax Expense | 94 | 99.7 | 116.4 | 104.5 | 126.6 | 45.6 | Upgrade |
Earnings From Continuing Operations | 226.5 | 240.1 | 263 | 241.2 | 301 | 110.2 | Upgrade |
Net Income to Company | 226.5 | 240.1 | 263 | 241.2 | 301 | 110.2 | Upgrade |
Net Income | 226.5 | 240.1 | 263 | 241.2 | 301 | 110.2 | Upgrade |
Net Income to Common | 226.5 | 240.1 | 263 | 241.2 | 301 | 110.2 | Upgrade |
Net Income Growth | -13.62% | -8.71% | 9.04% | -19.87% | 173.14% | -20.89% | Upgrade |
Shares Outstanding (Basic) | 226 | 226 | 226 | 226 | 226 | 198 | Upgrade |
Shares Outstanding (Diluted) | 228 | 228 | 228 | 228 | 228 | 199 | Upgrade |
Shares Change (YoY) | 0.02% | -0.05% | -0.03% | 0.01% | 14.34% | 0.06% | Upgrade |
EPS (Basic) | 1.00 | 1.06 | 1.16 | 1.07 | 1.33 | 0.56 | Upgrade |
EPS (Diluted) | 0.99 | 1.05 | 1.15 | 1.06 | 1.32 | 0.55 | Upgrade |
EPS Growth | -13.63% | -8.67% | 9.07% | -19.91% | 138.88% | -20.89% | Upgrade |
Free Cash Flow | 395.1 | 500.4 | 606.8 | 215.4 | 515 | 542.3 | Upgrade |
Free Cash Flow Per Share | 1.74 | 2.20 | 2.66 | 0.94 | 2.26 | 2.72 | Upgrade |
Dividend Per Share | 0.690 | 0.690 | 0.780 | 0.700 | 0.880 | 0.195 | Upgrade |
Dividend Growth | -9.21% | -11.54% | 11.43% | -20.46% | 351.28% | -61.00% | Upgrade |
Gross Margin | 45.93% | 46.31% | 46.22% | 46.77% | 47.96% | 44.96% | Upgrade |
Operating Margin | 9.50% | 10.02% | 11.11% | 11.07% | 13.58% | 7.49% | Upgrade |
Profit Margin | 5.71% | 6.18% | 6.92% | 6.79% | 8.72% | 3.90% | Upgrade |
Free Cash Flow Margin | 9.97% | 12.89% | 15.96% | 6.07% | 14.91% | 19.19% | Upgrade |
EBITDA | 457.7 | 470.7 | 496.8 | 458.7 | 538.3 | 267.4 | Upgrade |
EBITDA Margin | 11.55% | 12.12% | 13.06% | 12.92% | 15.59% | 9.46% | Upgrade |
D&A For EBITDA | 81.3 | 81.5 | 74.4 | 65.7 | 69.5 | 55.9 | Upgrade |
EBIT | 376.4 | 389.2 | 422.4 | 393 | 468.8 | 211.5 | Upgrade |
EBIT Margin | 9.50% | 10.02% | 11.11% | 11.07% | 13.58% | 7.49% | Upgrade |
Effective Tax Rate | 29.33% | 29.34% | 30.68% | 30.23% | 29.61% | 29.27% | Upgrade |
Revenue as Reported | 3,971 | 3,891 | 3,807 | 3,551 | 3,454 | 2,825 | Upgrade |
Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.